Atlas Trials

Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial

Clinical trial NCT02049307 · COMPLETED

Trial details

NCT number
NCT02049307
Sponsor
Hennepin Healthcare Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
InflammationFibrosis
Start date
2014-10-16
Primary completion
2018-12-14
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.